Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1575_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
10.10.2026
Размер:
7 Мб
Скачать
☆
220
24. Spillane AJ, Tucker M, Pasquali S.A pilot study reporting outcomes for melanoma patients of
a minimal access ilio-inguinal dissection technique based on two incisions. Ann Surg Oncol.
2011;18(4):970–6.
25. La-Touche S, Ayres B, Lam W, Alnajjar HM, Perry M, Watkin N.Trial of ligation versus coag-
ulation of lymphatics in dynamic inguinal sentinel lymph node biopsy for staging of squamous
cell carcinoma of the penis. Ann R Coll Surg Engl. 2012;94(5):344–6.
26. Lumachi F, Burelli P, Basso SM, Iacobone M, Ermani M.Usefulness of ultrasound scissors in
reducing serous drainage after axillary dissection for breast cancer: a prospective randomized
clinical study. Am Surg. 2004;70(1):80–4.
27. Iovino F, Auriemma PP, Ferraraccio F, Antoniol G, Barbarisi A. Preventing seroma for-
mation after axillary dissection for breast cancer: a randomized clinical trial. Am JSurg.
2012;203(6):708–14.
28. Matthey-Gié ML, Gié O, Deretti S, Demartines N, Matter M.Prospective randomized study
to compare lymphocele and lymphorrhea control following inguinal and axillary therapeu-
tic lymph node dissection with or without the use of an ultrasonic scalpel. Ann Surg Oncol.
2016;23(5):1716–20.
29. White I, Mills JK, Diggs B, Fortino Hima J, Ellis MC, etal. Sentinel lymph node biopsy for mel-
anoma: comparison of lymphocele rates by surgical technique. Am Surg. 2013;79(4):388–92.
30. Weldrick C, Bashar K, O'Sullivan TA, Gillis E, Clarke Moloney M, etal. A comparison of
brin sealant versus standard closure in the reduction of postoperative morbidity after groin
dissection: a systematic review and meta-analysis. Eur JSurg Oncol. 2014;40(11):1391–8.
31. Carless PA, Henry DA. Systematic review and meta-analysis of the use of brin sealant to
prevent seroma formation after breast cancer surgery. Br JSurg. 2006;93(7):810–9.
32. Boccardo F, De Cian F, Campisi CC, Molinari L, Spinaci S, Dessalvi S, etal. Surgical pre-
vention and treatment of lymphedema after lymph node dissection in patients with cutaneous
melanoma. Lymphology. 2013;46(1):20–6.
33. Catalona WJ.Modied inguinal lymphadenectomy for carcinoma of the penis with preserva-
tion of saphenous veins: technique and preliminary results. JUrol. 1988;140(2):306–10.
34. Pearlman NW, Robinson WA, Dreiling LK, McIntyre RC Jr, Gonzales R. Modied ilioin-
guinal node dissection for metastatic melanoma. Am JSurg. 1995;170(6):647–9. discussion
649–50
35. Zhang SH, Sood AK, Sorosky JI, Anderson B, Buller RE.Preservation of the saphenous vein
during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the
vulva. Cancer. 2000;89(7):1520–5.
36. Zhang X, Sheng X, Niu J, Li H, Li D, Tang L, etal. Sparing of saphenous vein during inguinal
lymphadenectomy for vulval malignancies. Gynecol Oncol. 2007;105(3):722–6.
37. Dardarian TS, Gray HJ, Morgan MA, Rubin SC, Randall TC.Saphenous vein sparing during
inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma. Gynecol
Oncol. 2006;101(1):140–2.
38. Kehoe S, Luesley D, Chan KK.A pilot study on early post-operative morbidity and technique
of inguinal node dissection in vulval carcinoma. Eur JGynaecol Oncol. 1998;19(4):374–6.
39. Abbas S, Seitz M.Systematic review and meta-analysis of the used surgical techniques to reduce
leg lymphedema following radical inguinal nodes dissection. Surg Oncol. 2011;20(2):88–96.
40. AbuRahma AF, Woodruff BA, Lucente FC.Edema after femoropopliteal bypass surgery: lym-
phatic and venous theories of causation. JVasc Surg. 1990;11(3):461–7.
41. Suzuki M, Unno N, Yamamoto N, Nishiyama M, Sagara D, Tanaka H, et al. Impaired lym-
phatic function recovered after great saphenous vein stripping in patients with varicose vein:
venodynamic and lymphodynamic results. JVasc Surg. 2009;50(5):1085–91.
42. Lawton G, Rasque H, Ariyan S.Preservation of muscle fascia to decrease lymphedema after
complete axillary and ilioinguinofemoral lymphadenectomy for melanoma. JAm Coll Surg.
2002;195(3):339–51.
A. Sommariva
221
43. Micheletti L, Borgno G, Barbero M, Preti M, Cavanna L, Nicolaci P, etal. Deep femoral
lymphadenectomy with preservation of the fascia lata. Preliminary report on 42 invasive vul-
var carcinomas. JReprod Med. 1990;35(12):1130–4.
44. Rouzier R, Haddad B, Dubernard G, Dubois P, Paniel BJ.Inguinofemoral dissection for carci-
noma of the vulva: effect of modications of extent and technique on morbidity and survival.
JAm Coll Surg. 2003;196(3):442–50.
45. Bouchot O, Rigaud J, Maillet F, Hetet JF, Karam G.Morbidity of inguinal lymphadenectomy
for invasive penile carcinoma. Eur Urol. 2004;45(6):761–5.
46. Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. Int J Gynaecol Obstet.
2012;119(Suppl 2):S90–6.
47. Way S.Carcinoma of the vulva. Am J Obstet Gynecol. 1960;79:692–7.
48. Judson PL, Jonson AL, Paley PJ, Bliss RL, Murray KP, Downs LS Jr, etal. A prospective,
randomized study analyzing sartorius transposition following inguinal-femoral lymphadenec-
tomy. Gynecol Oncol. 2004;95(1):226–30.
49. Bartlett EK, Meise C, Bansal N, Fischer JP, Low DW, Czerniecki BJ, etal. Sartorius transposi-
tion during inguinal lymphadenectomy for melanoma. JSurg Res. 2013;184(1):209–15.
50. Li L, Kou X, Feng X, Liu F, Chao H, Wang L.Clinical application of sartorius tendon trans-
position during radical vulvectomy: a case control study of 58 cases at a single institution.
JGynecol Oncol. 2015;26(4):320–6.
51. Benoit L, Boichot C, Cheynel N, Arnould L, Chauffert B, Cuisenier J, etal. Preventing lymph-
edema and morbidity with an omentum ap after ilioinguinal lymph node dissection. Ann Surg
Oncol. 2005;12(10):793–9.
52. Logmans A, Kruyt RH, de Bruin HG, Cox PH, Pillay M, Trimbos JB. Lymphedema and
lymphocysts following lymphadenectomy may be prevented by omentoplasty: A pilot study.
Gynecol Oncol. 1999;75(3):323–7.
53. Murthy V, Gopinath KS.Reconstruction of groin defects following radical inguinal lymphad-
enectomy: an evidence based review. Indian JSurg Oncol. 2012;3(2):130–8.
54. Thomson DR, Sadideen H, Furniss D.Wound drainage following groin dissection for malig-
nant disease in adults. Cochrane Database Syst Rev. 2014;11(11):CD010933.
14 Other Approaches forReducing Surgical Risk
223© Springer International Publishing AG 2018
K.A. Delman, V.A. Master (eds.), Malignancies of the Groin,
https://doi.org/10.1007/978-3-319-60858-7_15
Chapter 15
Surgical andAnatomic Considerations
ofMalignancies Affecting theGroin:
Reconstructive Approaches totheGroin
SeyedAmirhosseinRazavi, KaranA.Desai, AlbertLiao, andAlbertLosken
There has been an increasing demand for reconstructive surgery in acute or chronic
groin wounds resulting from burn, trauma patients with oncologic defects following
groin lymphadenectomy due to urogenital and lower limb malignancies and compli-
cations of infrainguinal vascular bypass surgeries [1–6]. The reconstructive surgeon
has to select the optimal soft tissue coverage after considering the patient’s comor-
bidities, postoperative quality of life, and functional outcome. In this chapter, we
will review the reconstructive options regarding complex wounds in the inguinal
region, a brief description of the reconstructive technique, reported outcomes, and
comparison between options including use of grafts and aps.

Primary Closure

Primary closure is always preferred when possible due to lower morbidity. Using
the reconstructive ladder as a guideline, primary reconstruction is the most direct
form of reconstruction and can be used in a variety of traumatic wounds and skin
cancer excisions [7, 8]. Primary closure however is often not possible in wounds
that are wide and have been previously irradiated.
S.A. Razavi, M.D. • K.A. Desai, M.D. • A. Liao, M.D.
A. Losken, M.D., F.A.C.S. (
*)
Division of Plastic Surgery, Department of Surgery,
Emory University Hospital Midtown, Emory University School of Medicine,
Medical Ofce Tower, 550 Peachtree Street, SE Suite 9000, Atlanta, GA 30308, USA
e-mail: srazavi@emory.edu; karan.desai@emory.edu; albert.liao@emory.edu;
alosken@emory.edu
224

Skin Graft

Skin graft is the transfer of skin from a donor site to a recipient site. When primary
closure is not possible secondary to a large defect, a skin graft may be used. In con-
trast to ap reconstruction, skin grafts develop their blood supply by neovascular-
ization during the rst 48–72 h after transfer. Two types of skin grafts are
split- thickness and full-thickness skin grafts. Full-thickness skin grafts require more
time for revascularization but have less wound contracture prole. In general, full-
thickness skin grafts do not have a role in groin reconstruction secondary to the
overall large size of the wounds requiring coverage. Groin wounds are most often
covered by split-thickness skin grafts from the thigh, buttocks, or trunk and will
subsequently heal by epithelialization [8–10]. While split-thickness skin grafts are
versatile, their use is restricted in the presence of wounds with exposed vital struc-
tures such as bones, nerves, or femoral vessels. Furthermore, reconstruction of a
radiated groin wound requires coverage with a well-vascularized tissue to prevent
wound-healing complications. In these situations, the clinician should seek more
complex methods in the reconstructive ladder such as ap reconstruction [2, 11, 12].
Skin grafts are often used if a wound has been slow to heal and otherwise has a
healthy granulation bed or is a supercial defect with a well-vascularized layer sub-
cutaneous tissue above the vessels.

Flap Reconstruction

Flap reconstruction is the transfer of skin and underlying tissue, when it is lifted from
a donor site and moved to a recipient site with its blood supply. Pedicled aps have
their vascular supply connected anatomically throughout the ap transfer. Free aps
on the other hand are when vascular supply is disconnected from its donor supply dur-
ing transfer and reconnected microsurgically to a new vessel at or near the recipient
site. The free aps are often used when no local or pedicle ap is available.
Flap closures are particularly useful for a wound bed with compromised tissue
such as in infected or radiated wounds with exposed structures. They provide protec-
tion over exposed bones, nerves, or vessels in the wound; increase vascularization to
decient areas; decrease scar formation; and result in a tension-free closure [2, 13].
The main complication associated with ap reconstruction is the risk of vascular
compromise. When feasible, pedicled aps are always preferred over free aps.
Frequent postoperative ap checks including monitoring ap color, temperature,
capillary rell, appearance, and use of tissue oximetry and external and implantable
Dopplers are necessary for early diagnosis of ap vascular compromise [14–16].
Other potential complications of ap reconstruction include hematoma and seroma
formation, surgical site infections, and donor site complications.
There are many different local ap options for groin reconstruction, including
gracilis muscle ap (medial femoral circumex system), sartorius muscle ap
S.A. Razavi et al.
225
(supercial circumex iliac artery from the supercial femoral artery), omental ap
(right omental artery from the right gastroepiploic artery), tensor fascia lata ap
(ascending branch of lateral femoral circumex artery), anterolateral thigh ap
(descending branch of lateral femoral circumex artery), rectus abdominis ap
(deep inferior epigastric artery), and rectus femoris ap (descending branch of lat-
eral femoral circumex artery) (Figs.15.1 and 15.2).
abc
Fig. 15.1 Rectus myocutaneous ap reconstruction of right groin oncologic defect with exposed
vessels. (a) Pre-reconstruction, (b) post-reconstruction, (c) rst follow-up in the plastic surgery clinic
a b
Fig. 15.2 Another example of rectus myocutaneous ap reconstruction. (a) Pre-reconstruction,
(b) post-reconstruction
15 Surgical andAnatomic Considerations ofMalignancies Affecting theGroin
226
Regional muscle aps such as the gracilis muscle ap and the sartorius muscle
ap are usually useful for reconstruction of small groin defects [17–19]. Sartorius
aps and pedicled gracilis aps are safe and durable reconstructions for locally
infected or exposed vascular grafts and infected groin wound of <10cm. However,
as these aps consist only of muscle, a skin graft is often needed over the ap for
skin coverage in the event of a skin decit. In their retrospective review of 244 aps
used for complex groin wound reconstruction, Fischer etal. suggested the use of
prophylactic sartorius muscle ap for smaller, low-risk wounds, reserving rectus
femoris ap for larger, more complex wounds and anterolateral thigh for wounds
with larger cutaneous defect [20].
A retrospective review by Ducic and colleagues for the use of extended dissection
gracilis ap in high-risk patients with complex groin wounds requiring more coverage
than a standard gracilis ap concluded that the extended dissection gracilis ap has
greater arc of rotation and no restriction on postoperative ambulation or thigh abduc-
tion [21]. First described by Hason etal. [22] in the extended dissection gracilis ap
technique, after the identication of the pedicle, the muscle is divided proximally, and
pedicle dissection continues deeper to the adductor longus muscle, the perforators, and
the vascular network and can be extended all the way to the profunda femoris artery.
There does not appear to be a consensus rst choice ap option for large (>10cm)
groin defects; however, anterolateral thigh (ALT) ap (both as a pedicled and free
ap) and vertical rectus abdominis myocutaneous ap are considered highly versa-
tile and reliable for this type of defect [3, 7, 23]. In their retrospective review,
Lannon etal. determined that the pedicled ALT ap should be the ap of choice for
large groin defects. There are several techniques to preserve ap viability, including
suprafascial ap harvesting, extended harvesting of fascia, utilization of the fascia
to protect the pedicle, coharvest with the vastus lateralis, and preservation of large
lateral rectus femoris perforators [23].
A retrospective review by LoGiudice etal. looking at 39 patients who underwent
reconstruction with ALT ap and rectus abdominis ap demonstrated shorter time
to healing and lower rate of delayed postoperative complications in the ALT group.
Incisional hernias were of particular concern in rectus abdominis ap patients [4].
Aslim etal. [3] reported their use of ALT ap and vertical rectus abdominis muscu-
locutaneous (VRAM) ap for large groin defects, both resulting in consistent results
with little morbidity. Additionally, both aps have the benet of having donor sites
that can be closed primarily reducing donor site morbidity.
A review of 50 patients, who underwent VRAM (63%) and extended RAM
(37%) aps by Parrett etal., showed reliable coverage of irradiated thigh and groin
oncologic wounds. Extended RAM was used for contralateral and more distal
defects. Parret reported signicantly improved results when performing immediate
compared to delayed reconstruction [5].
Comparing vertical and oblique RAM aps in 71 patients, Combs and colleagues
reported similar complication rates between the two reconstruction techniques.
They concluded that an oblique RAM ap is a safe alternative to VRAM with
advantages including greater arc of rotation, thinner skin paddle, less bulk, and lim-
ited fascial harvest [24].
S.A. Razavi et al.
227
Alkon etal. [25] reviewed their experience with rectus femoris muscle aps as
an effective and reliable mean for complex groin wound reconstruction. This ap is
harvested through a mid-anterior incision extending over the distal two-thirds of the
thigh, with muscle elevated on its pedicle and transposed into the groin wound
defect. They reported no ap losses and no donor site complications in the 37 rectus
femoris aps performed between 1999 and 2003. Reoperation was required in four
patients, one for ap readvancement and three for prosthetic vascular graft removal.
A cost analysis study by Chatterjee and colleagues comparing sartorius (n=234)
versus rectus femoris (n= 62) ap in the treatment of the infected vascular groin
graft wounds notes that the rectus femoris ap is the more cost-effective option with
less major complication prole [26].
In conclusion, evaluation for complex groin wound reconstruction starts with
considering patients’ comorbidities, postoperative quality of life, and functional
outcome and going through the reconstructive ladder. The reconstructive surgeon
should always consider primary reconstruction and skin grafting as rst options and
then move to more complex reconstruction options such as pedicled and free aps.
The gracilis and sartorius aps are useful options for reconstruction of smaller,
low-risk groin wounds (<10cm), while anterolateral thigh ap and vertical rectus
abdominis myocutaneous ap are reliable options for reconstruction of larger groin
defects.

References

1. Horch R, Stark GB.Prosthetic vascular graft infection--defect covering with delayed vertical
rectus abdominis muscular ap (VRAM) and rectus femoris ap. Vasa. 1994;23:52–6.
2. Murthy V, Gopinath KS.Reconstruction of groin defects following radical inguinal lymphad-
enectomy: an evidence based review. Indian JSurg Oncol. 2012;3:130–8.
3. Aslim EJ, Rasheed MZ, Lin F, Ong YS, Tan BK.Use of the anterolateral thigh and vertical
rectus abdominis musculocutaneous aps as utility aps in reconstructing large groin defects.
Arch Plast Surg. 2014;41:556–61.
4. LoGiudice JA, Haberman K, Sanger JR.The anterolateral thigh ap for groin and lower
abdominal defects: a better alternative to the rectus abdominis ap. Plast Reconstr Surg.
2014;133:162–8.
5. Parrett BM, Winograd JM, Garfein ES, Lee WP, Hornicek FJ, etal. The vertical and extended
rectus abdominis myocutaneous ap for irradiated thigh and groin defects. Plast Reconstr
Surg. 2008;122:171–7.
6. Perez-Burkhardt JL, Gonzalez-Fajardo JA, Carpintero LA, Mateo AM. Sartorius myo-
plasty for the treatment of infected groins with vascular grafts. JCardiovasc Surg (Torino).
1995;36:581–5.
7. Larson JD, Altman AM, Bentz ML, Larson DL.Pressure ulcers and perineal reconstruction.
Plast Reconstr Surg. 2014;133:39e–48e.
8. Simman R. Wound closure and the reconstructive ladder in plastic surgery. JAm Col Certif
Wound Spec. 2009;1:6–11.
9. Ratner D.Skin grafting. Semin Cutan Med Surg. 2003;22:295–305.
10. Ogawa R, Hyakusoku H, Ono S.Useful tips for successful skin grafting. JNippon Med Sch.
2007;74:386–92.
11. Fujioka M.Surgical Reconstruction of Radiation Injuries. Adv Wound Care (New Rochelle).
2014;3:25–37.
15 Surgical andAnatomic Considerations ofMalignancies Affecting theGroin
228
12. Payne WG, Walusimbi MS, Blue ML, Mosiello G, Wright TE, etal. Radiated groin wounds:
pitfalls in reconstruction. Am Surg. 2003;69:994–7.
13. Schoeman BJ.The tensor fascia lata myocutaneous ap in reconstruction of inguinal skin
defects after radical lymphadenectomy. S Afr JSurg. 1995;33:175–8.
14. Lin SJ, Nguyen MD, Chen C, Colakoglu S, Curtis MS, etal. Tissue oximetry monitoring in
microsurgical breast reconstruction decreases ap loss and improves rate of ap salvage. Plast
Reconstr Surg. 2011;127:1080–5.
15. Lohman RF, Langevin CJ, Bozkurt M, Kundu N, Djohan R.A prospective analysis of free ap
monitoring techniques: physical examination, external Doppler, implantable Doppler, and tis-
sue oximetry. JReconstr Microsurg. 2013;29:51–6.
16. Sinna R, Boloorchi A, Mahajan AL, Qassemyar Q, Robbe M.What should dene a “perforator
ap”? Plast Reconstr Surg. 2010;126:2258–63.
17. Maser B, Vedder N, Rodriguez D, Johansen K.Sartorius myoplasty for infected vascular grafts
in the groin. Safe, durable, and effective. Arch Surg. 1997;132:522–5. discussion 525-526
18. Chen SH, Hentz VR, Wei FC, Chen YR.Short gracilis myocutaneous aps for vulvoperineal
and inguinal reconstruction. Plast Reconstr Surg. 1995;95:372–7.
19. Shih PK, Cheng HT, Wu CI, Chang SC, Chen HC, etal. Management of infected groin wounds
after vascular surgery. Surg Infect (Larchmt). 2013;14:325–30.
20. Fischer JP, Mirzabeigi MN, Sieber BA, Nelson JA, Wu LC, et al. Outcome analysis of
244 consecutive aps for managing complex groin wounds. JPlast Reconstr Aesthet Surg.
2013;66:1396–404.
21. Ducic I, Dayan JH, Attinger CE, Curry P.Complex perineal and groin wound reconstruc-
tion using the extended dissection technique of the gracilis ap. Plast Reconstr Surg.
2008;122:472–8.
22. Hasen KV, Gallegos ML, Dumanian GA. Extended approach to the vascular pedicle of the
gracilis muscle ap: anatomical and clinical study. Plast Reconstr Surg. 2003;111:2203–8.
23. Lannon DA, Ross GL, Addison PD, Novak CB, Lipa JE, etal. Versatility of the proximally
pedicled anterolateral thigh ap and its use in complex abdominal and pelvic reconstruction.
Plast Reconstr Surg. 2011;127:677–88.
24. Combs PD, Sousa JD, Louie O, Said HK, Neligan PC, etal. Comparison of vertical and
oblique rectus abdominis myocutaneous aps for pelvic, perineal, and groin reconstruction.
Plast Reconstr Surg. 2014;134:315–23.
25. Alkon JD, Smith A, Losee JE, Illig KA, Green RM, et al. Management of complex groin
wounds: preferred use of the rectus femoris muscle ap. Plast Reconstr Surg. 2005;115:776–
83. discussion 784–75
26. Chatterjee A, Kosowski T, Pyfer B, Fisher CS, Tchou JC, etal. A cost-utility analysis compar-
ing the sartorius versus the rectus femoris ap in the treatment of the infected vascular groin
graft wound. Plast Reconstr Surg. 2015;135:1707–14.
S.A. Razavi et al.
229© Springer International Publishing AG 2018
K.A. Delman, V.A. Master (eds.), Malignancies of the Groin,
https://doi.org/10.1007/978-3-319-60858-7_16
Chapter 16
Quality ofLife andOutcomes inPatients
withMalignancies oftheGroin
AndrewJ.Lambour andSandraL.Wong

Introduction

Malignancies of the groin can be generally categorized as primary tumors or as
regional spread of disease to the inguinal lymph nodes. Prognosis and overall sur-
vival are generally related to the natural history of the underlying tumor type as well
as available treatment options. Because of the specic anatomic considerations of
the groin, it is important to note that malignancies of the groin have a serious impact
on the quality of life (QoL) of patients. Oftentimes, this impact occurs as the result
of the uncontrolled or progressive disease process or as the direct result of compli-
cations of treatment for either primary or secondary disease. As such, QoL consid-
erations span the entire continuum of cancer care, including preemptive or primary
operations to longer-term posttreatment effects.
This chapter will provide an overview of QoL, why QoL is important, and how
QoL is measured, as well as touch upon the specics of how certain disease states
impact QoL. The four diseases to be covered in this chapter include melanoma,
penile cancer, soft tissue sarcoma, and vulvar cancer. Related QoL considerations
can include mild symptoms of lymphedema to painful, bulky disease. Generally
speaking, there has been little research on the topic despite the severe implications
that it has on a patient’s overall health.
A.J. Lambour, M.D. • S.L. Wong, M.D., M.S. (*)
Department of Surgery, Dartmouth-Hitchcock Medical Center, Geisel School
of Medicine at Dartmouth, Lebanon, NH, USA
e-mail: Andrew.J.Lambour@hitchcock.org; Sandra.L.Wong@hitchcock.org
230
What Is “Quality ofLife”?
Aristotle’s Nicomachean Ethics provides one of the earliest denitions of quality of
life. In his discourse on happiness, Aristotle states, “what constitutes happiness is a
matter of dispute… some say one thing and some say another, indeed very often the
same man says different things at different times: when he falls sick he thinks health
is happiness, when he is poor wealth.” This in fact informs present-day discussions,
when the World Health Organization (WHO) denes health as “a state of complete
physical, mental, and social well-being, and not merely the absence of disease” [1].
There is actually no consensus as to what constitutes QoL.Much of this stems
from the fact that QoL is inherently subjective and personal. It is because of this
subjectivity that there exists a deep, indescribable sense of what “quality of life” is.
It is ineffable; one may know it when he or she sees it, and physicians may under-
stand it when a patient describes it. QoL is a complex construct, which can be
applied across a variety of contexts. Healthcare-related quality of life (HRQoL) is
the focus herein. Reasonable proposals for evaluating QoL capture the following
areas: general health, physical function, physical symptoms and toxicity, emotional
function, cognitive function, role function, social function, sexual function, and
existentialism. A possibly more parsimonious list includes categories of physical,
emotional, and social aspects of one’s life. Any complete denition or measurement
of QoL would ideally incorporate these dimensions.
Quality of life attributions are subjective—one patient’s perspective on QoL may be
very different from that of another patient. A patient’s quality of life is often affected
by a variety of issues related to their disease. Age, performance status, disease burden,
and tolerance of treatment may inuence a patient’s perspective on QoL.In addition to
this, there is a temporal aspect to QoL that may change as external factors or disease
processes change. Quantifying QoL is truly unlike many of the objective measure-
ments that are obtained in healthcare, such as quantied lab values.
Instruments used to measure QoL attempt to standardize and validate through an
objective and scientic manner. By quantifying QoL, one is able to make comparisons
and track changes over the course of care. Measurement of QoL must be patient driven
though scales used and reported by clinicians should be distinguished from patient-
reported outcomes (PROs)/patient-reported outcome measures (PROMs). The Food and
Drug Administration denes “patient-reported outcomes” as any report of the status of
a patient’s health condition that comes directly from the patient, without interpretation
by a clinician or anyone else. As would be expected, there has been great interest in
PROs/PROMs, but they have yet to be used widely in clinical practice. As such, there are
many methodologic challenges, and currently, there is not enough known about their
reliability and how to aggregate the data for longitudinal measurement of performance.
Why Is Assessment ofQuality ofLife Important?
From its measurement in clinical trials to its impact on treatment decisions, QoL plays
a tremendous role in decision-making around care that is provided to patients. Ultimately,
QoL is one of the major drivers when taking overarching goals of care into account.
A.J. Lambour and S.L. Wong